| Literature DB >> 34131321 |
Kang Zhang1,2, Xiaohong Liu3, Jie Xu4,5, Jin Yuan6, Wenjia Cai6, Ting Chen7, Kai Wang5, Yuanxu Gao8, Sheng Nie9, Xiaodong Xu5, Xiaoqi Qin5, Yuandong Su10, Wenqin Xu10, Andrea Olvera10, Kanmin Xue11, Zhihuan Li10, Meixia Zhang10, Xiaoxi Zeng10,12, Charlotte L Zhang13, Oulan Li13, Edward E Zhang13, Jie Zhu14, Yiming Xu3, Daniel Kermany10, Kaixin Zhou13, Ying Pan15, Shaoyun Li16, Iat Fan Lai17, Ying Chi18, Changuang Wang19, Michelle Pei8, Guangxi Zang8, Qi Zhang20, Johnson Lau21, Dennis Lam21,22, Xiaoguang Zou23, Aizezi Wumaier23, Jianquan Wang23, Yin Shen24, Fan Fan Hou9, Ping Zhang5, Tao Xu25, Yong Zhou26, Guangyu Wang27.
Abstract
Regular screening for the early detection of common chronic diseases might benefit from the use of deep-learning approaches, particularly in resource-poor or remote settings. Here we show that deep-learning models can be used to identify chronic kidney disease and type 2 diabetes solely from fundus images or in combination with clinical metadata (age, sex, height, weight, body-mass index and blood pressure) with areas under the receiver operating characteristic curve of 0.85-0.93. The models were trained and validated with a total of 115,344 retinal fundus photographs from 57,672 patients and can also be used to predict estimated glomerulal filtration rates and blood-glucose levels, with mean absolute errors of 11.1-13.4 ml min-1 per 1.73 m2 and 0.65-1.1 mmol l-1, and to stratify patients according to disease-progression risk. We evaluated the generalizability of the models for the identification of chronic kidney disease and type 2 diabetes with population-based external validation cohorts and via a prospective study with fundus images captured with smartphones, and assessed the feasibility of predicting disease progression in a longitudinal cohort.Entities:
Year: 2021 PMID: 34131321 DOI: 10.1038/s41551-021-00745-6
Source DB: PubMed Journal: Nat Biomed Eng ISSN: 2157-846X Impact factor: 25.671